Private Equity
Entrepreneur-friendly deal terms continued in the third quarter, according to two new reports on venture capital valuations and term sheets.
1 min read · 21 November 2013
GrowthWorks Canadian Fund has been provided legal authorization to begin a sale investor solicitation process. The authorization, which was provided by the Ontario Superior Court of Justice under the Companies' Creditors Arrangement Act, faciliates contact with prospective strategic and financial partners about a potential merger, asset sale, or investment in the fund. The venture capital fund has in past been affiliated with Vancouver-based GrowthWorks.
5 min read · 21 November 2013
Studies by Fenwick & West and Cooley find that nearly three-fourths of deals are up rounds
1 min read · 21 November 2013
Americans are living longer and spending more. That’s why some people think the “gray market” is a golden opportunity.
3 min read · 21 November 2013
A series of new startups are gearing up to enter a market that has been long neglected by VCs
6 min read · 21 November 2013
1 min read · 20 November 2013
Blueline Bioscience, a Toronto-based biotech incubator launched earlier this year by U.S. venture capital firm Versant Ventures, has entered into a new partnership with Celgene Corp, a manufacturer of drug therapies for cancer and inflammatory disorders with headquarters in Summit, New Jersey. Under the terms of the collaboration, Celegene will have certain option rights with respect to early-stage life sciences companies launched by the incubator in such fields as oncology and inflammation. Versant Ventures recently established an office in Vancouver. Blueline Bioscience is located in the MaRS Discovery District.
3 min read · 20 November 2013
Storied VC will not be an investment partner in the firm’s next fund as he works to build Draper University
2 min read · 20 November 2013
VC-backed company in talks with buyers, including TPG Capital, about a deal
2 min read · 19 November 2013
European venture investments during October 2013
1 min read · 19 November 2013
